# The Deep Sedation for Ablation Study

Study · id `cardio:ct-nct03844841` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03844841](<https://clinicaltrials.gov/study/NCT03844841>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03844841

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

## Technical summary

Registry record NCT03844841. Randomized; single masking; primary purpose treatment. Start 2019-07-01 (actual); primary completion 2020-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 160 participants (enrolled count; ClinicalTrials.gov record NCT03844841, source copy `cardio:ctgov-nct03844841-2021-01-25`, retrieved 2026-10-26)
- Started: 2019-07-01 (actual) (ClinicalTrials.gov record NCT03844841, source copy `cardio:ctgov-nct03844841-2021-01-25`, retrieved 2026-10-26)
- Primary completion: 2020-12-31 (actual) (ClinicalTrials.gov record NCT03844841, source copy `cardio:ctgov-nct03844841-2021-01-25`, retrieved 2026-10-26)
- Completion: 2020-12-31 (actual) (ClinicalTrials.gov record NCT03844841, source copy `cardio:ctgov-nct03844841-2021-01-25`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT03844841, source copy `cardio:ctgov-nct03844841-2021-01-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03844841-2021-01-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Deep Sedation for Ablation Study
- Condition: Atrial Fibrillation
- Condition: Ablation
- Condition: Sedation
- Condition: Propofol
- Condition: Dexmedetomidine
- Intervention (Drug): Propofol
- Intervention (Drug): Dexmedetomidine
- Lead sponsor: Insel Gruppe AG, University Hospital Bern
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Insel Gruppe AG, University Hospital Bern (`cardio:org-insel-gruppe-ag-university-hospital-bern`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Electrophysiological differences of randomized deep sedation with dexmedetomidine versus propofol (`cardio:pubmed-39085782`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c94ea889756b454baadcf0a441025fa86a66dd76a0a0cb249ae5938728898908
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
